Samsung Biologics Obtains Four Global ISO Certifications

Meets rigorous requirements for drug substance and drug product.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Samsung Biologics, a CDMO, has obtained four global ISO certifications: ISO22301 (Business Continuity Management), ISO50001 (Energy Management), ISO45001 (Occupational Health and Safety Management), and ISO14001 (Effective Environmental Management) from the British Standards Institution (BSI).      Upon meeting rigorous requirements and standards for ISO certification, the updated BCMS, ISO22301:2019, was awarded to Samsung Biologics’ Contract Development Organization (CDO) along with re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters